3Kirbis S,Breskvar UD,Sabovic M. Inflammation markers in patients with coronary artery disease-comparison of intracoronary and systemic levels[J].Wiener Klinische Wochenschrift,2010,(02):31-34.
4Keskin O,Ulusoy RE,Kalemoglu M. White blood cell count and C-reactive protein predict short-term prognosis in acute myocardial infarction[J].Journal of International Medical Research,2004,(06):646-654.
5Pineda J,Marin F,Marco P. The prognostic value of biomarkers after a premature myocardial infarction[J].International Journal of Cardiology,2010,(03):249-254.
6Naber CK,Mehta RH,Jünger C. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction(from the German Acute Coronary Syndromes Registry)[J].American Journal of Cardiology,2009,(05):583-587.
7Gul A,Rahman MA,Jaleel A. Changes in glycosylated protein in type-2 diabetic patients with and without complications[J].J Ayub Med Coll Abbottsbad,2005,(03):33-37.
8Emma Wilmot,IskandarIdris. Early onset type 2 diabetes: risk factors, clinical impact and management[J]. Therapeu- tic Advances in Chronic Disease, 2014,5 (6) : 234-244.
9Berkowitz SA, Meigs JB, Wexler DJ. Age at type 2 diabetes onset and glycaemic control:results from the National health and Nutrition Examination Survey(NHANES)2005- 2010[J]. Diabetologia,2013,56(9) :2593-2600.
10Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes[J]. N Engl J Med, 2008,359(9) : 1577-1589.
